Wanneer een wetenschappelijk onderzoek wordt afgerond, is het belangrijk dat de resultaten worden gepubliceerd om zo informatie en resultaten te delen met andere wetenschappers en artsen.

Hieronder een lijst met een aantal recente publicaties over onderzoeken uitgevoerd door onze dienst Neurologie.

• Opioid withdrawel due to Twiddler's syndrome. Moens M, De Smedt A, Brouns R. Neurology 2011; in press
• Insulinlike growth factor I serum levels and ischemic stroke outcome. De Smedt A, Brouns R, De Raedt S, Wilczak N, Uyttenboogaart M, Luijckx GJ, De Keyser J Stroke 2011; in press
• Cognitive, affective and behavioural disturbances following vascular thalamic lesions: a review.De Witte L, Brouns R, Kavadias D, Engelborghs S, De Deyn PP, Mariën P. Cortex 2011; 47: 273-319
• Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran. De Smedt A, De Raedt S, Nieboer K, De Keyser J, Brouns R. Cerebrovasc Dis. 2010;30(5):533-4. Epub 2010 Sep 28.
• Delayed akinetic catatonic mutism following methadone overdose. Gheuens S, Michotte A, Flamez A, De Keyser J. Neurotoxicology. 2010 Dec;31(6):762-4. Epub 2010 Aug 3.
• Modifiable factors influencing relapses and disability in multiple sclerosis. D'hooghe MB, Nagels G, Bissay V, De Keyser J. Mult Scler. 2010 Jul;16(7):773-85. Epub 2010 May 18.
• Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis. De Keyser J, Laureys G, Demol F, Wilczak N, Mostert J, Clinckers R. Neurochem Int. 2010 Nov;57(4):446-50. Epub 2010 Feb 21.
• Astrocytic beta(2)-adrenergic receptors: from physiology to pathology. Laureys G, Clinckers R, Gerlo S, Spooren A, Wilczak N, Kooijman R, Smolders I, Michotte Y, De Keyser J. Prog Neurobiol. 2010 Jul;91(3):189-99.
• Fatigue as the presenting symptom of chronic inflammatory demyelinating polyneuropathy. Bissay V, Flamez A, Schmedding E, Ebinger G. Muscle Nerve. 2008 Dec;38(6):1653-7.
• Fatigue as the presenting symptom of chronic inflammatory demyelinating polyneuropathy. Bissay V, Flamez A, Schmedding E, Ebinger G. Muscle Nerve. 2008 Dec;38(6):1653-7.
• Progressive multifocal leukoencephalopathy as first manifestation of sarcoidosis. De Raedt S, Lacor P, Michotte A, Flamez A, Ebinger G. Clin Neurol Neurosurg. 2008 Feb;110(2):186-9.
• [Progressive multifocal leukoencephalopathy as first manifestation of sarcoidosis. De Raedt S, Lacor P, Michotte A, Flamez A, Ebinger G. Clin Neurol Neurosurg. 2008 Feb;110(2):186-9.
• Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Brouns R, Wauters A, De Surgeloose D, Mariën P, De Deyn PP. Eur Neurol. 2011;65(1):23-31. Epub 2010 Dec 7.
• The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke. Brouns R, Verkerk R, Aerts T, De Surgeloose D, Wauters A, Scharpé S, De Deyn PP. Neurochem Res. 2010 Sep;35(9):1315-22. Epub 2010 May 19.
• Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome. Brouns R, Wauters A, Van De Vijver G, De Surgeloose D, Sheorajpanday R, De Deyn PP. Clin Chem Lab Med. 2010 Mar;48(3):383-90.
• Ceulemans G, Verdries D, Versijpt J, Vanhove C, Everaert H Extrastriatal uptake on 123I-ioflupane brain SPECT Eur J Nucl Med Mol Imaging 2010;37:1048